Delivery of doxorubicin and paclitaxel from double-layered microparticles: The effects of layer thickness and dual-drug vs. single-drug loading
- 1 November 2015
- journal article
- research article
- Published by Elsevier in Acta Biomaterialia
- Vol. 27, 53-65
Abstract
No abstract availableKeywords
Funding Information
- (SCELSE) (M4330001.C70.703012)
- School of Materials Science and Engineering (M020070110)
- National Medical Research Council, Ministry of Health (NMRC/CIRG/1342/2012)
- (NTU-NHG) (ARG/14012)
- Biomedical Research Council (A∗STAR, Singapore)
This publication has 53 references indexed in Scilit:
- Drug delivery systems for differential release in combination therapyExpert Opinion on Drug Delivery, 2011
- Synergistic drug combinations tend to improve therapeutically relevant selectivityNature Biotechnology, 2009
- Engineered polymers for advanced drug deliveryEuropean Journal of Pharmaceutics and Biopharmaceutics, 2009
- Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles☆Advanced Drug Delivery Reviews, 2007
- Pharmacokinetics of combined doxorubicin and paclitaxel in miceCancer Letters, 2005
- Low-Dose Suramin Enhanced Paclitaxel Activity in Chemotherapy-Naïve and Paclitaxel-Pretreated Human Breast Xenograft TumorsClinical Cancer Research, 2004
- Interaction pharmacokinetics of pegylated liposomal doxorubicin (Caelyx) on coadministration with paclitaxel or docetaxelCancer Chemotherapy and Pharmacology, 2004
- Phase I Study of Paclitaxel (Taxol) and Pegylated Liposomal Doxorubicin (Caelyx) Administered Every 2 Weeks in Patients with Advanced Solid TumorsOncology, 2002
- Cremophor ELEuropean Journal of Cancer, 2001
- Liposome application: problems and prospectsCurrent Opinion in Colloid & Interface Science, 2001